Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00126932 · ClinicalTrials.gov registry record · Phase 4
Reduction of Topical Anesthetic Onset Time Using Ultrasound
A Phase 4 study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00126932 is a Phase 4 study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 70 participants.
The verdict
NCT00126932, a Phase 4 study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Children ages 3-7 who are undergoing blood drawing receive either standard care, topical medicine for numbing (LMX4), or the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The child's pain with the blood drawing procedure is evaluated.
Interventions
- DEVICE SonoPrep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-10 |
| Est. Completion | 2004-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00126932
The ClinicalTrials.gov registry entry for NCT00126932 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SonoPrep is the first listed.
NCT00126932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00126932 about?
NCT00126932 is a clinical study titled "Reduction of Topical Anesthetic Onset Time Using Ultrasound". Children ages 3-7 who are undergoing blood drawing receive either standard care, topical medicine for numbing (LMX4), or the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The child's pain with the blood drawing procedure is evaluated.
What is the current status of trial NCT00126932?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2004-10. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00126932?
The interventions under investigation include: SonoPrep (DEVICE).
Who is sponsoring clinical trial NCT00126932?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.